Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Anterior Transhepatic Approach for Caudate Lobectomy

[The Strategy of Isolated Complete Resection of the Caudate Lobe of the Liver Through the Anterior Liver-Splitting Approach: a Report of 19 Cases].

Surgical Treatment on Hepatocellular Carcinoma(HCC) with Bile Duct Tumor Thrombi

Management of Hepatocellular Carcinoma Rupture in the Caudate Lobe.

Total Laparoscopic Right Hemihepatectomy Through Anterior Approach for Larger Tumors in the Right Lobe of the Liver

Retrograde Resection of Caudate Lobe of Liver.

The update strategy of the isolated caudate lobe resection:A report of 21 cases

Anterior Approach for Complete Resection of Liver Caudate Lobe

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Surgical Treatment of Hepatocellular Carcinoma Originating from Caudate Lobe—a Report of 39 Cases

Surgical Indication and Strategy for Liver Hemangioma in the Caudate Lobe: a Multi-Institutional Retrospective Analysis with 137 Patients.

Complete Resection of the Caudate Lobe of the Liver with Tumor: Technique and Experience.

Total Laparoscopic Radical Resection for Bismuth Type Ⅲa Hilar Cholangiocarcinoma

Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma

Anatomic, isolated complete caudate lobectomy using an anterior transhepatic approach with glissonian pedicle approach and indocyanine green fluorescence guidance: a case report

Retrograde Caudate Lobectomy in 7 Cases

Caudate lobe resection for hepatic carcinoma

Laparoscopic Anatomical Resection of Paracaval Portion of Caudate Lobe and Segment 8 for HCC in an HCV-Related Cirrhotic Patient

Application of a New Approach for Laparoscopic Resection of Bismuth IIIa Hilar Cholangiocarcinoma

Discussion on the technique of resection of liver tumor in the caudate lobe

A Left-Sided, Purely Laparoscopic Approach for Anatomic Caudate Hepatectomy: A Single-Center Experience.